NDC 0054-4581 – Mercaptopurine
Mercaptopurine 50 mg/1 · Tablet · Oral
Product NDC0054-4581
Product details
- Brand name
- Mercaptopurine
- Generic name
- Mercaptopurine
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA040528
- Marketed since
- February 13, 2004
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Mercaptopurine 50 mg/1
Uses, dosage, side effects and warnings for Mercaptopurine →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0054-4581-11 | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) | Feb 13, 2004 |
| 0054-4581-27 | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) | Feb 13, 2004 |
Recalls mentioning this NDC
- D-1314-2014 May 14, 2014 · Class III
Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.
Other Mercaptopurine products
- 71921-150 Mercaptopurine 50 mg/1 · Tablet · Florida Pharmaceutical Products, LLC
- 51407-983 Mercaptopurine 50 mg/1 · Tablet · Golden State Medical Supply, Inc.
- 0054-0879 Mercaptopurine 20 mg/mL · Suspension · Hikma Pharmaceuticals USA Inc.
- 0054-4582 Mercaptopurine 20 mg/mL · Suspension · Hikma Pharmaceuticals USA Inc.
- 62484-1020 Mercaptopurine 20 mg/mL · Suspension · Nova Laboratories, Ltd